{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T20:57:20Z","timestamp":1767992240155,"version":"3.49.0"},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1097\/won.0000000000000214","type":"journal-article","created":{"date-parts":[[2016,3,3]],"date-time":"2016-03-03T11:38:24Z","timestamp":1457005104000},"page":"254-259","source":"Crossref","is-referenced-by-count":11,"title":["Cilostazol Can Increase Skin Oxygen Supply Assessed by Transcutaneous Oxygen Pressure Measurement in Type 2 Diabetes With Lower Limb Ischemic Disease"],"prefix":"10.1097","volume":"43","author":[{"given":"Jinglu","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zidong","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lihong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haiyun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Baoming","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lifang","family":"Mai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chuan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-7-20210211","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1056\/NEJMoa0908292","article-title":"Prevalence of diabetes among men and women in China","volume":"362","author":"Yang","year":"2010","journal-title":"N Engl J Med"},{"key":"R2-7-20210211","first-page":"737","article-title":"Management of ischemic diabetic foot","volume":"54","author":"Caravaggi","year":"2013","journal-title":"J Cardiovasc Surg (Torino"},{"key":"R3-7-20210211","doi-asserted-by":"crossref","first-page":"3","DOI":"10.14797\/mdcj-8-4-3","article-title":"Critical limb ischemia: advanced medical therapy","volume":"8","author":"Davies","year":"2012","journal-title":"Methodist Debakey Cardiovasc J"},{"key":"R4-7-20210211","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.ejvs.2006.11.022","article-title":"Vascular involvement in diabetic subjects with ischemic foot ulcer: a new morphologic categorization of disease severity","volume":"33","author":"Graziani","year":"2007","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"R5-7-20210211","first-page":"386","article-title":"High-risk diabetic patients with unprotected left main coronary artery disease: characteristics and medium-term outcomes of percutaneous revascularization with drug-eluting stents","volume":"38","author":"Fernandez","year":"2011","journal-title":"Tex Heart Inst J"},{"key":"R6-7-20210211","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1177\/1479164112465443","article-title":"Microcirculatory vasomotor changes are associated with severity of peripheral neuropathy in patients with type 2 diabetes","volume":"10","author":"Sun","year":"2013","journal-title":"Diab Vasc Dis Res"},{"key":"R7-7-20210211","first-page":"27","article-title":"Wound healing and care in the infected diabetic foot","volume":"50","author":"McCartney","year":"2001","journal-title":"West Indian Med J"},{"key":"R8-7-20210211","doi-asserted-by":"crossref","first-page":"147","DOI":"10.2337\/diacare.22.1.147","article-title":"Transcutaneous oxygen tension and toe blood pressure as predictors for outcome of diabetic foot ulcers","volume":"22","author":"Kalani","year":"1999","journal-title":"Diabetes Care"},{"key":"R9-7-20210211","doi-asserted-by":"crossref","first-page":"625","DOI":"10.2337\/diacare.21.4.625","article-title":"Angiographic evaluation of peripheral arterial occlusive disease and its role as a prognostic determinant for major amputation in diabetic subjects with foot ulcers","volume":"21","author":"Faglia","year":"1998","journal-title":"Diabetes Care"},{"key":"R10-7-20210211","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1097\/PHM.0b013e3182876a06","article-title":"Noninvasive arterial studies including transcutaneous oxygen pressure measurements with the limbs elevated or dependent to predict healing after partial foot amputation","volume":"92","author":"Andrews","year":"2013","journal-title":"Am J Phys Med Rehabil"},{"key":"R11-7-20210211","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1001\/archinte.1990.00390130117018","article-title":"The influence of age, sex, smoking, and diabetes on lower limb transcutaneous oxygen tension in patients with arterial occlusive disease","volume":"150","author":"Rooke","year":"1990","journal-title":"Arch Intern Med"},{"key":"R12-7-20210211","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/0741-5214(92)90196-F","article-title":"Predictive value of transcutaneous oxygen pressure and amputation success by use of supine and elevation measurements","volume":"15","author":"Bacharach","year":"1992","journal-title":"J Vasc Surg"},{"key":"R13-7-20210211","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1177\/153473460200100303","article-title":"Noninvasive measurement techniques for monitoring of microvascular function in the diabetic foot","volume":"1","author":"Cobb","year":"2002","journal-title":"Int J Low Extrem Wounds"},{"key":"R14-7-20210211","first-page":"CR273","article-title":"Predictive value of routine transcutaneous tissue oxygen tension (tcpO2) measurement for the risk of non-healing and amputation in diabetic foot ulcer patients with non-palpable pedal pulses","volume":"16","author":"Ladurner","year":"2010","journal-title":"Med Sci Monit"},{"key":"R15-7-20210211","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1177\/1538574406291824","article-title":"Transcutaneous oxygen and carbon dioxide levels with iloprost administration in diabetic critical limb ischemia","volume":"40","author":"Melillo","year":"2006","journal-title":"Vasc Endovascular Surg"},{"issue":"6921","key":"R16-7-20210211","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1136\/bmj.308.6921.81","article-title":"Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists Collaboration.","volume":"308","year":"1994","journal-title":"BMJ"},{"key":"R17-7-20210211","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1161\/01.CIR.98.7.678","article-title":"Cilostazol has beneficial effects in treatment of intermittent claudication: results from a multicenter, randomized, prospective, double-blind trial","volume":"98","author":"Dawson","year":"1998","journal-title":"Circulation"},{"key":"R18-7-20210211","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1001\/archinte.159.17.2041","article-title":"A new pharmacological treatment for intermittent claudication: results of a randomized, multicenter trial","volume":"159","author":"Beebe","year":"1999","journal-title":"Arch Intern Med"},{"key":"R19-7-20210211","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1167\/iovs.12-10115","article-title":"Dilation of porcine retinal arterioles to cilostazol: roles of eNOS phosphorylation via cAMP\/protein kinase A and AMP-activated protein kinase and potassium channels","volume":"54","author":"Tanano","year":"2013","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R20-7-20210211","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.diabet.2011.06.003","article-title":"Painful diabetic neuropathy: diagnosis and management","volume":"37","author":"Hartemann","year":"2011","journal-title":"Diabetes Metab"},{"key":"R21-7-20210211","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1177\/1538574408328586","article-title":"The vascular and biochemical effects of cilostazol in diabetic patients with peripheral arterial disease","volume":"43","author":"O'Donnell","year":"2009","journal-title":"Vasc Endovascular Surg"},{"key":"R22-7-20210211","doi-asserted-by":"crossref","first-page":"503","DOI":"10.5551\/jat.3392","article-title":"Anti-inflammatory role of cilostazol in vascular smooth muscle cells in vitro and in vivo","volume":"17","author":"Aoki","year":"2010","journal-title":"J Atheroscler Thromb"},{"key":"R23-7-20210211","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1093\/cvr\/cvn226","article-title":"Cilostazol inhibits cytokine-induced nuclear factor-kappaB activation via AMP-activated protein kinase activation in vascular endothelial cells","volume":"81","author":"Hattori","year":"2009","journal-title":"Cardiovasc Res"},{"key":"R24-7-20210211","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0014-2999(98)00015-6","article-title":"Cilostazol, a selective cAMP phosphodiesterase inhibitor, dilates retinal arterioles and increases retinal and choroidal blood flow in rats","volume":"344","author":"Hotta","year":"1998","journal-title":"Eur J Pharmacol"},{"key":"R25-7-20210211","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.metabol.2013.09.006","article-title":"The hypolipidemic effect of cilostazol can be mediated by regulation of hepatic low-density lipoprotein receptor-related protein 1 (LRP1) expression","volume":"63","author":"Kim","year":"2014","journal-title":"Metabolism"},{"key":"R26-7-20210211","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.atherosclerosis.2003.08.017","article-title":"Reduction of remnant lipoprotein cholesterol concentrations by cilostazol in patients with intermittent claudication","volume":"171","author":"Wang","year":"2003","journal-title":"Atherosclerosis"},{"key":"R27-7-20210211","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1053\/j.ajkd.2012.02.340","article-title":"Peripheral artery disease and CKD: a focus on peripheral artery disease as a critical component of CKD care","volume":"60","author":"Garimella","year":"2012","journal-title":"Am J Kidney Dis"},{"key":"R28-7-20210211","doi-asserted-by":"crossref","first-page":"25","DOI":"10.2165\/00003088-199937002-00003","article-title":"Effect of hepatic impairment on the pharmacokinetics of a single dose of cilostazol","volume":"37","author":"Bramer","year":"1999","journal-title":"Clin Pharmacokinet"}],"container-title":["Journal of Wound, Ostomy & Continence Nursing"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/WON.0000000000000214","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T07:24:32Z","timestamp":1620977072000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00152192-201605000-00007"}},"subtitle":["A Randomized Trial"],"short-title":[],"issued":{"date-parts":[[2016,5]]},"references-count":28,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/won.0000000000000214","relation":{},"ISSN":["1071-5754"],"issn-type":[{"value":"1071-5754","type":"print"}],"subject":[],"published":{"date-parts":[[2016,5]]}}}